1.The importance of synergy between trade and standards In today's global economy,trade development and standards cooperation must move in tandem to make cross-border transactions more rapid,more reliable,and more...1.The importance of synergy between trade and standards In today's global economy,trade development and standards cooperation must move in tandem to make cross-border transactions more rapid,more reliable,and more inclusive.As the digital transformation accelerates,rules and standards are increasing,posing a risk of marginalizing MSMEs.Professor Kim delivered eight keynote speeches in China in 2025.This article summarizes his opinions in the speeches.He identifies a critical operational chain:Trade→Standards→Evidence→Mutual recognition.This sequence reflects the institutional pathway through which trust is established in international trade:standards define common requirements,evidence provides verifiable proof that those requirements are met,and mutual recognition enables that proof to be accepted across borders.In practice,such evidence is generated through conformity assessment processes,which convert compliance with standards into verifiable results such as test reports,certifications,or audit findings.展开更多
1.Introduction Phase Ⅱ trials are typically designed to identify promising treatment therapies that warrant further investigation in subsequent phase Ⅲ con-firmatory trials,playing a vital role in evidence generatio...1.Introduction Phase Ⅱ trials are typically designed to identify promising treatment therapies that warrant further investigation in subsequent phase Ⅲ con-firmatory trials,playing a vital role in evidence generation of drug de-velopment.The basic design features of phase II trials include interim go/no-go decisions to prevent exposing too many patients to poten-tially ineffective treatments.Appropriate go/no-go decisions and effi-cient trial designs can shorten the research duration and increase trial success rates.展开更多
文摘1.The importance of synergy between trade and standards In today's global economy,trade development and standards cooperation must move in tandem to make cross-border transactions more rapid,more reliable,and more inclusive.As the digital transformation accelerates,rules and standards are increasing,posing a risk of marginalizing MSMEs.Professor Kim delivered eight keynote speeches in China in 2025.This article summarizes his opinions in the speeches.He identifies a critical operational chain:Trade→Standards→Evidence→Mutual recognition.This sequence reflects the institutional pathway through which trust is established in international trade:standards define common requirements,evidence provides verifiable proof that those requirements are met,and mutual recognition enables that proof to be accepted across borders.In practice,such evidence is generated through conformity assessment processes,which convert compliance with standards into verifiable results such as test reports,certifications,or audit findings.
基金funded by Beijing Nova Program(grant number:20230484277)National Natural Science Foundation of China(grant number:82303955).
文摘1.Introduction Phase Ⅱ trials are typically designed to identify promising treatment therapies that warrant further investigation in subsequent phase Ⅲ con-firmatory trials,playing a vital role in evidence generation of drug de-velopment.The basic design features of phase II trials include interim go/no-go decisions to prevent exposing too many patients to poten-tially ineffective treatments.Appropriate go/no-go decisions and effi-cient trial designs can shorten the research duration and increase trial success rates.
